Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction. Jia L, Li G, Ma N, Zhang A, et al. BMC Cancer 2022;22:760.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jia L, Li G, Ma N, Zhang A, et al. Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction. BMC Cancer 2022;22:760.
PMID: 35831854